Home approves fda
 

Keywords :   


Tag: approves fda

U.S. FDA approves 'Star Wars' robotic arm for amputees

2014-05-10 15:18:30| Automakers - Topix.net

The U.S. Food and Drug Administration has approved a robotic arm for amputees that is named for the "Star Wars" character Luke Skywalker and can perform multiple, simultaneous movements, a huge advance over the metal hook currently in use.

Tags: star wars arm star wars

 

FDA approves a life-like prosthetic arm from the man who invented the Segway

2014-05-10 14:18:34| Automakers - Topix.net

After years of testing, the FDA today approved a new type of prosthetic arm that its makers claim will bring a whole new level of control to amputees.

Tags: the man arm invented

 
 

U.S. FDA approves Merck blood clot preventer

2014-05-09 16:22:54| Biotech - Topix.net

U .S. health regulators on Thursday approved a blood clot preventer developed by Merck & Co for use by patients who have had a heart attack or who suffer from blockages in the arteries of the legs.

Tags: blood fda approves merck

 

FDA Approves The Patheon Site In Bourgoin, France To Manufacture Drugs For U.S. Market

2014-05-09 16:12:50| drugdiscoveryonline News Articles

Patheon , the pharmaceutical services business owned by DPx Holdings, recently received FDA approval for its Bourgoin, France site to begin manufacturing and selling drugs to the U.S. market. The Bourgoin site specializes in development and commercial scale manufacture of solid oral forms and non-sterile liquids.

Tags: site us france market

 

FDA Approves Mercks RAGWITEK (Short Ragweed Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults

2014-04-18 00:22:00| Merck.com - Product News

Dateline City: WHITEHOUSE STATION, N.J. RAGWITEK is the First and Only FDA Approved Sublingual Allergen Immunotherapy Tablet Indicated for the Treatment of Short Ragweed Pollen Allergies WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved RAGWITEK (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (12 Amb a 1-U). Language: English Contact: MerckMedia Contacts:Pamela Eisele, 267-305-3558Robert Consalvo, 908-423-6595orInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: without short treat adults

 

Sites : [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] next »